FIELD: medicine.
SUBSTANCE: group concerns a composition for the target elimination of mutation escape from anti-cancer therapeutic agent; a kit for eliciting the immune response, wherein the kit comprises the above composition. The compositions containing yeast carriers are applied in a combination with the other anti-cancer therapeutic agents.
EFFECT: group of invention provides the minimisation and complete elimination of the stability to the agent or higher effectiveness of the agent, or the minimisation, reduction or complete elimination of some symptoms of the disease.
20 cl, 2 ex, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOTHERAPEUTIC COMPOSITIONS BASED ON YEAST WITH BRACHYURY | 2012 |
|
RU2619850C2 |
| YEAST-BASED IMMUNOTHERAPEUTIC COMPOSITIONS WITH BRACHYURY | 2012 |
|
RU2690180C2 |
| IMMUNOTHERAPEUTIC COMPOSITIONS ON THE BASIS OF YEAST-MUC1 AND METHODS OF THEIR USE | 2012 |
|
RU2642300C2 |
| METHODS FOR PREDICTION OF APPLICABILITY OF PROTEINS OR PROTEIN FRAGMENTS FOR IMMUNOTHERAPY | 2017 |
|
RU2782336C2 |
| YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA | 2014 |
|
RU2679806C2 |
| IMMUNOPROPHYLACTIC CANCER VACCINE | 2004 |
|
RU2556128C2 |
| CONDITIONALLY ACTIVE CHIMERIC ANTIGEN RECEPTORS FOR MODIFIED T-CELLS | 2015 |
|
RU2764074C2 |
| PREVENTIVE CANCER VACCINE | 2004 |
|
RU2385163C2 |
| TYPES OF COMBINATION THERAPY FOR TREATING CANCER | 2021 |
|
RU2816314C1 |
| ANTICANCER VACCINES TARGETING BORIS AND METHODS OF THEIR APPLICATION | 2018 |
|
RU2759681C1 |
